{"database": "lobbying", "table": "lobbying_filings_raw", "rows": [["776f96f7-e6a2-4b44-bbcb-e0444efe0063", "Q1", 17443, "HANCE SCARBOROUGH", 123133, "TITAN PHARMACEUTICALS, INC.", 2018, "first_quarter", "2018-04-18T16:18:37.537000-04:00", null, 0, 0, 0, "{\"url\": \"https://lda.senate.gov/api/v1/filings/776f96f7-e6a2-4b44-bbcb-e0444efe0063/\", \"filing_uuid\": \"776f96f7-e6a2-4b44-bbcb-e0444efe0063\", \"filing_type\": \"Q1\", \"filing_type_display\": \"1st Quarter - Report\", \"filing_year\": 2018, \"filing_period\": \"first_quarter\", \"filing_period_display\": \"1st Quarter (Jan 1 - Mar 31)\", \"filing_document_url\": \"https://lda.senate.gov/filings/public/filing/776f96f7-e6a2-4b44-bbcb-e0444efe0063/print/\", \"filing_document_content_type\": \"text/html\", \"income\": null, \"expenses\": null, \"expenses_method\": null, \"expenses_method_display\": null, \"posted_by_name\": \"Jay B. Stewart\", \"dt_posted\": \"2018-04-18T16:18:37.537000-04:00\", \"termination_date\": null, \"registrant_country\": \"United States of America\", \"registrant_ppb_country\": null, \"registrant_address_1\": \"400 W. 15th Street, Suite 950\", \"registrant_address_2\": null, \"registrant_different_address\": false, \"registrant_city\": \"AUSTIN\", \"registrant_state\": \"TX\", \"registrant_zip\": \"78701\", \"registrant\": {\"id\": 17443, \"url\": \"https://lda.senate.gov/api/v1/registrants/17443/\", \"house_registrant_id\": 30333, \"name\": \"HANCE SCARBOROUGH\", \"description\": \"Law Firm\", \"address_1\": \"412 1st St SE\", \"address_2\": \"Suite One\", \"address_3\": null, \"address_4\": null, \"city\": \"Washington\", \"state\": \"DC\", \"state_display\": \"District of Columbia\", \"zip\": \"20003\", \"country\": \"US\", \"country_display\": \"United States of America\", \"ppb_country\": \"US\", \"ppb_country_display\": \"United States of America\", \"contact_name\": \"JAY B. STEWART\", \"contact_telephone\": \"+1 512-479-8888\", \"dt_updated\": \"2026-01-26T16:22:32.262741-05:00\"}, \"client\": {\"id\": 123133, \"url\": \"https://lda.senate.gov/api/v1/clients/123133/\", \"client_id\": 1004342, \"name\": \"TITAN PHARMACEUTICALS, INC.\", \"general_description\": \"Specialty pharmaceuticals company\", \"client_government_entity\": false, \"client_self_select\": null, \"state\": \"CA\", \"state_display\": \"California\", \"country\": \"US\", \"country_display\": \"United States of America\", \"ppb_state\": \"CA\", \"ppb_state_display\": \"California\", \"ppb_country\": \"US\", \"ppb_country_display\": \"United States of America\", \"effective_date\": \"2018-02-01\"}, \"lobbying_activities\": [{\"general_issue_code\": \"BUD\", \"general_issue_code_display\": \"Budget/Appropriations\", \"description\": \"Medicare/Medicaid drug coverage,opioid addiction policy, S.2456 The CARA 2.0 Act of 2018.\", \"foreign_entity_issues\": \"\", \"lobbyists\": [{\"lobbyist\": {\"id\": 10001, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"KENT\", \"nickname\": null, \"middle_name\": \"R\", \"last_name\": \"HANCE\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 66821, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"MICHAEL\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"TOMBERLIN\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": \"Chief of Staff, Rep. Chip Cravaack, Chief of Staff, REp. Louie Gohmert\", \"new\": false}], \"government_entities\": [{\"id\": 2, \"name\": \"HOUSE OF REPRESENTATIVES\"}, {\"id\": 1, \"name\": \"SENATE\"}]}, {\"general_issue_code\": \"MED\", \"general_issue_code_display\": \"Medical/Disease Research/Clinical Labs\", \"description\": \"Medicare/Medicaid drug coverage,opioid addiction policy, S.2456 The CARA 2.0 Act of 2018.\", \"foreign_entity_issues\": \"\", \"lobbyists\": [{\"lobbyist\": {\"id\": 10001, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"KENT\", \"nickname\": null, \"middle_name\": \"R\", \"last_name\": \"HANCE\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 66821, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"MICHAEL\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"TOMBERLIN\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": \"Chief of Staff, Rep. Chip Cravaack, Chief of Staff, Rep. Louie Gohmert\", \"new\": false}], \"government_entities\": [{\"id\": 2, \"name\": \"HOUSE OF REPRESENTATIVES\"}, {\"id\": 1, \"name\": \"SENATE\"}]}, {\"general_issue_code\": \"MMM\", \"general_issue_code_display\": \"Medicare/Medicaid\", \"description\": \"Medicare/Medicaid drug coverage,opioid addiction policy, S.2456 The CARA 2.0 Act of 2018.\", \"foreign_entity_issues\": \"\", \"lobbyists\": [{\"lobbyist\": {\"id\": 10001, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"KENT\", \"nickname\": null, \"middle_name\": \"R\", \"last_name\": \"HANCE\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 66821, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"MICHAEL\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"TOMBERLIN\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": \"Chief of Staff, Rep. Chip Cravaack, Chief of Staff, Rep. Louie Gohmert\", \"new\": false}], \"government_entities\": [{\"id\": 2, \"name\": \"HOUSE OF REPRESENTATIVES\"}, {\"id\": 1, \"name\": \"SENATE\"}]}, {\"general_issue_code\": \"PHA\", \"general_issue_code_display\": \"Pharmacy\", \"description\": \"Medicare/Medicaid drug coverage,opioid addiction policy, S.2456 The CARA 2.0 Act of 2018.\", \"foreign_entity_issues\": \"\", \"lobbyists\": [{\"lobbyist\": {\"id\": 10001, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"KENT\", \"nickname\": null, \"middle_name\": \"R\", \"last_name\": \"HANCE\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 66821, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"MICHAEL\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"TOMBERLIN\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": \"Chief of Staff, Rep. Chip Cravaack, Chief of Staff, Rep. Louie Gohmert\", \"new\": false}], \"government_entities\": [{\"id\": 2, \"name\": \"HOUSE OF REPRESENTATIVES\"}, {\"id\": 1, \"name\": \"SENATE\"}]}], \"conviction_disclosures\": [], \"foreign_entities\": [], \"affiliated_organizations\": []}"]], "columns": ["filing_uuid", "filing_type", "registrant_id", "registrant_name", "client_id", "client_name", "filing_year", "filing_period", "received_date", "amount_reported", "is_amendment", "is_no_activity", "is_termination", "raw_json"], "primary_keys": ["filing_uuid"], "primary_key_values": ["776f96f7-e6a2-4b44-bbcb-e0444efe0063"], "units": {}, "query_ms": 20.32971801236272, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}